Is ONCT stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
On Friday 17th of October 2014, Oncternal Therapeutics had a stock price of $826.00. If you invested back then, your return now would be a loss of $-824.57 per share or -99.83%
No, the average daily trading liquidity for Oncternal Therapeutics is $77 386 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Oncternal Therapeutics has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Oncternal Therapeutics to be medium [0.7 out of 1]